Applicants having applied for permission to cultivate and handle cannabis

Updated 31 July 2019
Theme image medicinal cannabis with tex

To accommodate the considerable interest from the industry and the media, the Danish Medicines Agency has decided to publish the names of the companies having applied for authorisation to cultivate and handle cannabis with the intention of developing cannabis for medicinal use.

The following companies have (as at 31 July 2019) applied for permission to cultivate and handle cannabis with the intention of developing cannabis for medicinal use:

Applicants whose applications are pending a decision:

  • ProCann ApS
  • Atlas Growers Denmark A/S
  • CanAct ApS
  • JV Trading IVS
  • Steffen Knudsen
  • DK Cannabis Europe ApS
  • Carham ApS

 

Applicants who have been granted authorisations:

  • Cannabis-International ApS (authorisation sent 15 July 2019)
  • Sterigenics Denmark A/S (authorisation sent 18 June 2019)
  • Solace Denmark ApS (authorisation sent 6 June 2019)
  • Vertanical Denmark A/S (authorisation sent 29 May 2019)
  • Orenda ApS (authorisation sent 29 May 2019)
  • Valeus IVS  (authorisation sent 7 May 2019)
  • Cronus APS (authorisation sent 7 May 2019)
  • Aureum A/S (authorisation sent 6 May 2019)
  • Rangers Pharmaceuticals A/S (authorisation sent 3 May 2019)
  • Organic Cannabis Care (authorisation sent 3 May 2019)
  • Teknologisk Institut (authorisation sent 3 May 2019)
  • TGOD Genetics A/S (authorisation sent 5 April 2019)
  • MM Danish Cannabis (authorisation sent 21 March 2019)
  • Mother Room IVS (authorisation sent 28 February 2019)
  • Canna Therapeutic ApS (authorisation sent 3 January 2019)
  • Pharmacan IVS (authorisation sent 22 November 2018)
  • Vibegårds Gartneri A/S (authorisation sent 24 July 2018)
  • DANCANN (authorisation sent 20 June 2018)
  • Drizzle Grow IVS (authorisation sent 23 May 2018)
  • Schroll Medical ApS (authorisation sent 12 April 2018)
  • Gartneriet Gårslev A/S (authorisation sent 23 March 2018)
  • Nordic Cannabis ApS (authorisation sent 23 March 2018)
  • Copenhagen Cannabis IVS (authorisation sent 23 March 2018)
  • Æssense Europe ApS (authorisation sent 12 January 2018)
  • Gistrup Green Grow (authorisation sent 15 December 2017)
  • Cannabis Pharm, earlier MM Bureau v/Morten Nøhr Mortensen (authorisation sent 15 December 2017)
  • Cantiva ApS (authorisation sent 15 December 2017)
  • Aurora Nordic Cannabis A/S, earlier Scandinavian Cannabis A/S (authorisation sent 15 December 2017)
  • D.W. IVS (authorisation sent 15 December 2017)
  • Canopy Growth Denmark ApS, earlier Spectrum Cannabis Denmark ApS (authorisation sent 15 December 2017)
  • Hemp Valley ApS (authorisation sent 15 December 2017)
  • MEDICAN ApS (authorisation sent 15 December 2017)
  • StenoCare A/S, earlier StenoCare IVS (authorisation sent 15 December 2017)

 

Applicants whose applications have been refused or have expired:

  • Medibo Relief (the application expired 16 July 2019)
  • Nordic Cannabis Pharmaceuticals (refusal sent 3 June 2019)
  • Søndersø Invest (refusal sent January 2019)
  • Danaca ApS (refusal sent 14 December 2018)
  • Medical Cannabis Denmark (the application is expired 21 December 2018)
  • THANSEN (refusal sent 13 november 2018)
  • CanFarm ApS (refusal sent 11 October 2018)
  • Baylinq (refusal sent 21 December 2017)
  • Yoldas Akkaya (refusal sent 1 December 2017)

 

Applicants whose applications have been withdrawn

  • Scientific Leaf I/S
  • Moffes.com ApS 
  • Poulsen Roser A/S
  • CanFarm ApS

 

 

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.